138 related articles for article (PubMed ID: 21894146)
1. Spleen tyrosine kinase promotes acute neutrophil-mediated glomerular injury via activation of JNK and p38 MAPK in rat nephrotoxic serum nephritis.
Ryan J; Ma FY; Kanellis J; Delgado M; Blease K; Nikolic-Paterson DJ
Lab Invest; 2011 Dec; 91(12):1727-38. PubMed ID: 21894146
[TBL] [Abstract][Full Text] [Related]
2. ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis.
Amos LA; Ma FY; Tesch GH; Liles JT; Breckenridge DG; Nikolic-Paterson DJ; Han Y
J Cell Mol Med; 2018 Sep; 22(9):4522-4533. PubMed ID: 29998485
[TBL] [Abstract][Full Text] [Related]
3. An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis.
Han Y; Ma FY; Di Paolo J; Nikolic-Paterson DJ
Int J Immunopathol Pharmacol; 2018; 32():2058738418783404. PubMed ID: 29923438
[TBL] [Abstract][Full Text] [Related]
4. Myeloid cell-mediated renal injury in rapidly progressive glomerulonephritis depends upon spleen tyrosine kinase.
Ryan J; Ma FY; Han Y; Ozols E; Kanellis J; Tesch GH; Nikolic-Paterson DJ
J Pathol; 2016 Jan; 238(1):10-20. PubMed ID: 26251216
[TBL] [Abstract][Full Text] [Related]
5. Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis.
Stambe C; Atkins RC; Tesch GH; Kapoun AM; Hill PA; Schreiner GF; Nikolic-Paterson DJ
J Am Soc Nephrol; 2003 Feb; 14(2):338-51. PubMed ID: 12538734
[TBL] [Abstract][Full Text] [Related]
6. Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritis.
Stambe C; Atkins RC; Hill PA; Nikolic-Paterson DJ
Kidney Int; 2003 Dec; 64(6):2121-32. PubMed ID: 14633134
[TBL] [Abstract][Full Text] [Related]
7. Spleen tyrosine kinase contributes to acute renal allograft rejection in the rat.
Ramessur Chandran S; Tesch GH; Han Y; Woodman N; Mulley WR; Kanellis J; Blease K; Ma FY; Nikolic-Paterson DJ
Int J Exp Pathol; 2015 Feb; 96(1):54-62. PubMed ID: 25529862
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory actions of Syk inhibitors in macrophages involve non-specific inhibition of toll-like receptors-mediated JNK signaling pathway.
Lin YC; Huang DY; Chu CL; Lin WW
Mol Immunol; 2010 Apr; 47(7-8):1569-78. PubMed ID: 20138367
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide-induced c-Jun NH2-terminal kinase activation in human neutrophils: role of phosphatidylinositol 3-Kinase and Syk-mediated pathways.
Arndt PG; Suzuki N; Avdi NJ; Malcolm KC; Worthen GS
J Biol Chem; 2004 Mar; 279(12):10883-91. PubMed ID: 14699155
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation.
Mugabe BE; Yaghini FA; Song CY; Buharalioglu CK; Waters CM; Malik KU
J Pharmacol Exp Ther; 2010 Jan; 332(1):116-24. PubMed ID: 19797620
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat.
Ma FY; Flanc RS; Tesch GH; Bennett BL; Friedman GC; Nikolic-Paterson DJ
Lab Invest; 2009 Apr; 89(4):470-84. PubMed ID: 19188913
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 induces contraction via a Syk-mediated p38 mitogen-activated protein kinase pathway in rat aortic smooth muscle.
Lee HM; Won KJ; Kim J; Park HJ; Kim HJ; Roh HY; Lee SH; Lee CK; Kim B
J Pharmacol Sci; 2007 Apr; 103(4):427-33. PubMed ID: 17409631
[TBL] [Abstract][Full Text] [Related]
13. A role for spleen tyrosine kinase in renal fibrosis in the mouse obstructed kidney.
Ma FY; Blease K; Nikolic-Paterson DJ
Life Sci; 2016 Feb; 146():192-200. PubMed ID: 26779657
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha.
Suzuki K; Hino M; Hato F; Tatsumi N; Kitagawa S
Blood; 1999 Jan; 93(1):341-9. PubMed ID: 9864179
[TBL] [Abstract][Full Text] [Related]
15. A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis.
Smith J; McDaid JP; Bhangal G; Chawanasuntorapoj R; Masuda ES; Cook HT; Pusey CD; Tam FW
J Am Soc Nephrol; 2010 Feb; 21(2):231-6. PubMed ID: 19959716
[TBL] [Abstract][Full Text] [Related]
16. Expression and mechanism of spleen tyrosine kinase activation by angiotensin II and its implication in protein synthesis in rat vascular smooth muscle cells.
Yaghini FA; Li F; Malik KU
J Biol Chem; 2007 Jun; 282(23):16878-90. PubMed ID: 17442668
[TBL] [Abstract][Full Text] [Related]
17. TNF activates Syk protein tyrosine kinase leading to TNF-induced MAPK activation, NF-kappaB activation, and apoptosis.
Takada Y; Aggarwal BB
J Immunol; 2004 Jul; 173(2):1066-77. PubMed ID: 15240695
[TBL] [Abstract][Full Text] [Related]
18. Syk contributes to PDGF-BB-mediated migration of rat aortic smooth muscle cells via MAPK pathways.
Lee CK; Lee HM; Kim HJ; Park HJ; Won KJ; Roh HY; Choi WS; Jeon BH; Park TK; Kim B
Cardiovasc Res; 2007 Apr; 74(1):159-68. PubMed ID: 17303097
[TBL] [Abstract][Full Text] [Related]
19. A pathogenic role for JNK signaling in experimental anti-GBM glomerulonephritis.
Flanc RS; Ma FY; Tesch GH; Han Y; Atkins RC; Bennett BL; Friedman GC; Fan JH; Nikolic-Paterson DJ
Kidney Int; 2007 Sep; 72(6):698-708. PubMed ID: 17597698
[TBL] [Abstract][Full Text] [Related]
20. Hydroxychloroquine suppresses anti-GBM nephritis via inhibition of JNK/p38 MAPK signaling.
Torigoe M; Obata Y; Inoue H; Torigoe K; Kinoshita A; Koji T; Mukae H; Nishino T
Clin Exp Nephrol; 2023 Feb; 27(2):110-121. PubMed ID: 36264415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
